Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-31
DOI
10.1038/s41416-022-01732-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantile regression models for survival data with missing censoring indicators
- (2021) Zhiping Qiu et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- 751P Survival prognostic and surrogate values of the early modeled CA-125 KELIM in newly diagnosed advanced ovarian cancer: Data from the GCIG meta-analysis group
- (2021) P. Corbaux et al. ANNALS OF ONCOLOGY
- The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas
- (2021) Benoit You et al. CANCER TREATMENT REVIEWS
- Differential benefit from fractionated dose-dense first-line chemotherapy for epithelial ovarian cancer (EOC) according to KELIM-evaluated tumor primary chemosensitivity: Exploratory analyses of ICON-8 trial.
- (2021) Benoit You et al. JOURNAL OF CLINICAL ONCOLOGY
- CA-125 ELIMination rate constant K (KELIM) Is A Marker Of Chemosensitivity In Patients With Ovarian Cancer: Results from the Phase II CHIVA trial
- (2020) Benoît You et al. CLINICAL CANCER RESEARCH
- The forefront of ovarian cancer therapy: update on PARP inhibitors
- (2020) M.R. Mirza et al. ANNALS OF ONCOLOGY
- Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
- (2020) Paul DiSilvestro et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
- (2020) William P. Tew et al. JOURNAL OF CLINICAL ONCOLOGY
- 847P The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands
- (2020) L. Van Wagensveld et al. ANNALS OF ONCOLOGY
- Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by BRCA and homologous recombination status: PRIMA/ENGOT-OV26/GOG-3012 study
- (2020) B.J. Monk et al. GYNECOLOGIC ONCOLOGY
- Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
- (2019) Olivier Colomban et al. CLINICAL CANCER RESEARCH
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started